1. Home
  2. DNOW vs RLAY Comparison

DNOW vs RLAY Comparison

Compare DNOW & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNOW
  • RLAY
  • Stock Information
  • Founded
  • DNOW 1862
  • RLAY 2015
  • Country
  • DNOW United States
  • RLAY United States
  • Employees
  • DNOW N/A
  • RLAY N/A
  • Industry
  • DNOW Metal Fabrications
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DNOW Industrials
  • RLAY Health Care
  • Exchange
  • DNOW Nasdaq
  • RLAY Nasdaq
  • Market Cap
  • DNOW 1.4B
  • RLAY 1.1B
  • IPO Year
  • DNOW N/A
  • RLAY 2020
  • Fundamental
  • Price
  • DNOW $14.71
  • RLAY $4.64
  • Analyst Decision
  • DNOW Buy
  • RLAY Strong Buy
  • Analyst Count
  • DNOW 2
  • RLAY 9
  • Target Price
  • DNOW $15.50
  • RLAY $20.88
  • AVG Volume (30 Days)
  • DNOW 879.4K
  • RLAY 1.4M
  • Earning Date
  • DNOW 11-07-2024
  • RLAY 11-06-2024
  • Dividend Yield
  • DNOW N/A
  • RLAY N/A
  • EPS Growth
  • DNOW 59.45
  • RLAY N/A
  • EPS
  • DNOW 1.88
  • RLAY N/A
  • Revenue
  • DNOW $2,357,000,000.00
  • RLAY $10,006,000.00
  • Revenue This Year
  • DNOW $5.00
  • RLAY N/A
  • Revenue Next Year
  • DNOW $2.05
  • RLAY N/A
  • P/E Ratio
  • DNOW $7.83
  • RLAY N/A
  • Revenue Growth
  • DNOW 1.90
  • RLAY N/A
  • 52 Week Low
  • DNOW $9.44
  • RLAY $4.48
  • 52 Week High
  • DNOW $15.65
  • RLAY $12.14
  • Technical
  • Relative Strength Index (RSI)
  • DNOW 70.38
  • RLAY 23.64
  • Support Level
  • DNOW $14.16
  • RLAY $5.96
  • Resistance Level
  • DNOW $15.19
  • RLAY $6.39
  • Average True Range (ATR)
  • DNOW 0.53
  • RLAY 0.34
  • MACD
  • DNOW 0.11
  • RLAY -0.12
  • Stochastic Oscillator
  • DNOW 86.32
  • RLAY 7.92

About DNOW NOW Inc.

Dnow Inc is a company engaged in world-wide supplying of energy and industrial products and packaged, engineered process and production equipment with a legacy of over one sixty years. It offers a broad set of supply chain solutions combined with a suite of digital solutions branded as DigitalNOW that provide customers world-class technology for digital commerce, data and information management. Its locations provide products and solutions to exploration and production companies, midstream transmission and storage companies, refineries, chemical companies, utilities, mining, municipal water, manufacturers, engineering and construction companies as well as companies operating in the decarbonization, energy transition and renewables end markets.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: